|
HY-134820-100mg
|
MedChemexpress LLC
|
MLT-943 [CAS 1832576-04-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-134820-5mg
|
MedChemexpress LLC
|
MLT-943 [CAS 1832576-04-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-134820-50mg
|
MedChemexpress LLC
|
MLT-943 [CAS 1832576-04-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-134820-1mL
|
MedChemexpress LLC
|
MLT-943 [CAS 1832576-04-1] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-N0502-10mg
|
MedChemexpress LLC
|
Mogroside V [CAS 88901-36-4]
|
|
Cancer-programmed cell death
|
|
|
HY-N0502-5mg
|
MedChemexpress LLC
|
Mogroside V [CAS 88901-36-4]
|
|
Cancer-programmed cell death
|
|
|
HY-N0502-50mg
|
MedChemexpress LLC
|
Mogroside V [CAS 88901-36-4]
|
|
Cancer-programmed cell death
|
|
|
HY-N0502-1mL
|
MedChemexpress LLC
|
Mogroside V [CAS 88901-36-4] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-N0316-1mg
|
MedChemexpress LLC
|
Mollugin [CAS 55481-88-4]
|
|
Cancer-programmed cell death
|
|
|
HY-N0316-10mg
|
MedChemexpress LLC
|
Mollugin [CAS 55481-88-4]
|
|
Cancer-programmed cell death
|
|
|
HY-N0316-20mg
|
MedChemexpress LLC
|
Mollugin [CAS 55481-88-4]
|
|
Cancer-programmed cell death
|
|
|
HY-N0316-5mg
|
MedChemexpress LLC
|
Mollugin [CAS 55481-88-4]
|
|
Cancer-programmed cell death
|
|
|
HY-N3245-10mg
|
MedChemexpress LLC
|
Moracin C [CAS 69120-06-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-N3245-5mg
|
MedChemexpress LLC
|
Moracin C [CAS 69120-06-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-N3244-5mg
|
MedChemexpress LLC
|
Moracin O [CAS 123702-97-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-N3243-1mg
|
MedChemexpress LLC
|
Moracin P [CAS 102841-46-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-N3243-10mg
|
MedChemexpress LLC
|
Moracin P [CAS 102841-46-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-N3243-5mg
|
MedChemexpress LLC
|
Moracin P [CAS 102841-46-3]
|
|
COVID-19-immunoregulation
|
|
